A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-021-24156-y
Affiliations:
6
Authors:
17
Institutions Authors Share
University of Pittsburgh (Pitt), United States of America (USA)
16.166667
16.166667
0.95
Shanghai Jiao Tong University (SJTU), China
0.500000
0.03
McGowan Institute for Regenerative Medicine (MIRM), United States of America (USA)
0.333333
0.02